Granules India's Q2 FY 2025-26 Quarterly Results

Result Summary

• Granules India Ltd reported a 5.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 33.6%.
• Its expenses for the quarter were up by 6.1% QoQ and 33.1% YoY.
• The net profit increased 16.0% QoQ and increased 34.3% YoY.
• The earnings per share (EPS) of Granules India Ltd stood at 5.38 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Granules India Ltd is a well-established pharmaceutical company that primarily focuses on the production and distribution of pharmaceutical products. The company operates in the pharmaceutical industry, specializing in the manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages. Granules India Ltd is known for its integrated operations, which encompass the entire pharmaceutical value chain. As of the latest available information, the company has been focusing on expanding its manufacturing capabilities and increasing its market presence domestically and internationally. However, specific details on recent major developments or strategic initiatives undertaken by the company are not available at the moment.

Revenue

In the second quarter of fiscal year 2026 (Q2FY26), Granules India Ltd reported a total income of ₹1295.84 crores. This marks an increase from the previous quarter (Q1FY26), where the total income was ₹1226.45 crores, reflecting a quarter-over-quarter (QoQ) growth of 5.7%. Compared to the same quarter in the previous year (Q2FY25), where the total income was ₹969.87 crores, the year-over-year (YoY) growth stands at 33.6%. These figures indicate a strong revenue performance over the past year, with consistent growth in both quarterly and yearly comparisons.

Profitability

The profitability metrics for Granules India Ltd in Q2FY26 show an upward trend. The profit before tax (PBT) for the quarter was ₹175.86 crores, up from ₹144.52 crores in Q1FY26, representing a QoQ increase of 21.7%. When compared to Q2FY25, where the PBT was ₹128.38 crores, a YoY growth of 37.0% is observed. The company recorded a tax expense of ₹45.26 crores in Q2FY26, which increased from ₹31.89 crores in Q1FY26 and ₹31.15 crores in Q2FY25. The profit after tax (PAT) for Q2FY26 was ₹130.61 crores, marking a QoQ growth of 16.0% from ₹112.64 crores in Q1FY26 and a YoY growth of 34.3% from ₹97.23 crores in Q2FY25. These results reflect a positive trend in profitability metrics.

Operating Metrics

Granules India Ltd reported an earnings per share (EPS) of ₹5.38 in Q2FY26, which is an increase from ₹4.64 in Q1FY26, indicating a QoQ growth of 15.9%. Compared to Q2FY25, where the EPS was ₹4.01, there is a YoY growth of 34.2%. Total expenses for the company in Q2FY26 were ₹1119.97 crores, up from ₹1056.02 crores in Q1FY26, reflecting a QoQ increase of 6.1%. When compared to Q2FY25, with expenses of ₹841.49 crores, the YoY growth in expenses is 33.1%. These metrics indicate a growth in both revenue and expenses, with a notable increase in earnings per share over the measured periods.